All Pharma News
Larimar Therapeutics to Participate in Upcoming Investor Conferences

Larimar Therapeutics to Participate in Upcoming Investor Conferences
GLOBENEWSWIRE
27 Aug 2024
Share Share
Larimar Therapeutics Reports Second Quarter 2024 Operating and Financial Results

Larimar Therapeutics Reports Second Quarter 2024 Operating and Financial Results
GLOBENEWSWIRE
07 Aug 2024
Share Share
First rare disease therapies chosen for FDA START programme

First rare disease therapies chosen for FDA START programme
Phil Taylor PHARMAPHORUM
05 Jun 2024
Share Share
FDA picks Denali, Neurogene and more for rare disease program

FDA picks Denali, Neurogene and more for rare disease program
Helen Floersh FIERCE BIOTECH
04 Jun 2024
Share Share
Larimar In FDA START Pilot For Nomlabofusp In Friedreich`s Ataxia

Larimar In FDA START Pilot For Nomlabofusp In Friedreich`s Ataxia
GLOBENEWSWIRE
30 May 2024
Share Share
Larimar`s Friedreich`s ataxia program free at last from FDA hold

Larimar`s Friedreich`s ataxia program free at last from FDA hold
Annalee Armstrong FIERCE BIOTECH
21 May 2024
Share Share
Larimar: FDA Removes Partial Hold On Nomlabofusp Friedreich`s Program

Larimar: FDA Removes Partial Hold On Nomlabofusp Friedreich`s Program
GLOBENEWSWIRE
20 May 2024
Share Share
Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results

Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
GLOBENEWSWIRE
09 May 2024
Share Share
Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
GLOBENEWSWIRE
14 Mar 2024
Share Share
Larimar Announces the Dosing of the First Patient in Study for Nomlabofusp

Larimar Announces the Dosing of the First Patient in Study for Nomlabofusp
GLOBENEWSWIRE
11 Mar 2024
Share Share